A nanoliposome-based drug delivery system for cancer
| Contribuinte(s) |
Duan, Wei |
|---|---|
| Data(s) |
05/03/2013
|
| Resumo |
The current project shows that the sulfatide-containing nanoliposome (SCL) drug delivery system could be an effective and safe nanocarrier for the anticancer agent doxorubicin to target tumours with high expression of tenascin-C. Moreover, SCL encapsulation could be a new strategy for the treatment of diseases in the central nervous system. |
| Identificador | |
| Idioma(s) |
eng |
| Publicador |
Deakin University, Faculty of Health, School of Medicine |
| Relação |
http://dro.deakin.edu.au/eserv/DU:30061028/lin-agreement-2013.pdf http://dro.deakin.edu.au/eserv/DU:30061028/lin-nanoliposomebased-2013A.pdf |
| Direitos |
The Author. All Rights Reserved |
| Palavras-Chave | #Sulfatide-containing nanoliposome #Sulfatide-containing liposomal DOX (SCL-DOX ) #Liposomes #Cancer treatment |
| Tipo |
Thesis |
